Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Institut national de la recherche scientifique

$29,000.00

Molecular mechanisms by which estrogens affect male germ cell programming during development

FY 2020-21

Summary
Germ cell development in mammals represents a unique and complex process. The fetal and early postnatal windows of development are critical. Indeed, during this time window, germ cells (gonocytes) undergo epigenetic reprogramming, proliferation, quiescence and differentiation. Recent evidence have indicated that adult reproductive dysfunction can originate from misregulation of germ cell development during this specific period of development. We have demonstrated that this period of development is particularly sensitive to endocrine disruption by estrogen-like compounds. Yet, the signaling mechanisms and molecular basis involved in perinatal gonocyte programming and the targets of xenoestrogens remain poorly understood. My research program aims to elucidate the underlying molecular basis for fetal and neonatal male germ cell development in mammals and determining how the misregulation of these processes might alter reproductive function in adulthood. The central hypothesis is that the epigenetic reprogramming that occurs during gonocyte development, through de novo DNA methylation and histones post-translational modifications, regulates the expression of key regulators genes that are necessary for germ cell programming, and that such mechanism can be targeted by the estrogen signalling pathway. Taking advantages of a transgenic rat model in which only germ cells express the green fluorescent protein, we will elucidate how the estrogen signaling can affect gene expression and the epigenetic machinery in gonocytes by using both in vivo and in vitro models. In Objective 1, we will characterize the short-term impact of in vivo gestational exposure to ethinyl estradiol and genistein when gonocytes proliferate and de novo DNA methylation occurs. Comparison between treatments will discriminate between the two estrogen receptors pathways. The impact on gene expression will be evaluated using genome wide transcriptome analysis. Further analysis of the effect of treatment on epigenetic reprogramming and cell differentiation will be done. Finally, in depth comprehension of epigenetic regulation of genes which expression is affected by estrogenic treatment will be obtained. In Objective 2, we will use two in vitro models and pharmaceutical inhibitors to disrupt the enzymes involved in DNA methylation and histone modifications, we will reveal the crosstalk between the estrogen signaling and the epigenetic machinery in regulating gene expression in gonocytes. We will use an immortalized gonocyte cell line and organ culture to determine how the misregulation of epigenetic mechanisms regulates gonocytes proliferation, differentiation or cell death, and how estrogens alter such regulation. Altogether, these studies will provide a better understanding of how estrogens affect male germ cell development by targeting the epigenetic reprogramming. Fetal development represents a key and unique period in cell programming when cells acquire information for a lifetime. Understanding the molecular mechanisms underlying male germ cell programming and how xenobiotics can disrupt these mechanisms is essential to establish the dependency of reproductive outcomes on fetal programming.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2014-04607
Name nom
Delbes, Geraldine
Department département
Institut Armand Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2014
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Installment
inst:7-8
Partie
2
Nb partie
8
Application title
Molecular mechanisms by which estrogens affect male germ cell programming during development
Keyword
NSERC
Application summary
Germ cell development in mammals represents a unique and complex process. The fetal and early postnatal windows of development are critical. Indeed, during this time window, germ cells (gonocytes) undergo epigenetic reprogramming, proliferation, quiescence and differentiation. Recent evidence have indicated that adult reproductive dysfunction can originate from misregulation of germ cell development during this specific period of development. We have demonstrated that this period of development is particularly sensitive to endocrine disruption by estrogen-like compounds. Yet, the signaling mechanisms and molecular basis involved in perinatal gonocyte programming and the targets of xenoestrogens remain poorly understood. My research program aims to elucidate the underlying molecular basis for fetal and neonatal male germ cell development in mammals and determining how the misregulation of these processes might alter reproductive function in adulthood. The central hypothesis is that the epigenetic reprogramming that occurs during gonocyte development, through de novo DNA methylation and histones post-translational modifications, regulates the expression of key regulators genes that are necessary for germ cell programming, and that such mechanism can be targeted by the estrogen signalling pathway. Taking advantages of a transgenic rat model in which only germ cells express the green fluorescent protein, we will elucidate how the estrogen signaling can affect gene expression and the epigenetic machinery in gonocytes by using both in vivo and in vitro models. In Objective 1, we will characterize the short-term impact of in vivo gestational exposure to ethinyl estradiol and genistein when gonocytes proliferate and de novo DNA methylation occurs. Comparison between treatments will discriminate between the two estrogen receptors pathways. The impact on gene expression will be evaluated using genome wide transcriptome analysis. Further analysis of the effect of treatment on epigenetic reprogramming and cell differentiation will be done. Finally, in depth comprehension of epigenetic regulation of genes which expression is affected by estrogenic treatment will be obtained. In Objective 2, we will use two in vitro models and pharmaceutical inhibitors to disrupt the enzymes involved in DNA methylation and histone modifications, we will reveal the crosstalk between the estrogen signaling and the epigenetic machinery in regulating gene expression in gonocytes. We will use an immortalized gonocyte cell line and organ culture to determine how the misregulation of epigenetic mechanisms regulates gonocytes proliferation, differentiation or cell death, and how estrogens alter such regulation. Altogether, these studies will provide a better understanding of how estrogens affect male germ cell development by targeting the epigenetic reprogramming. Fetal development represents a key and unique period in cell programming when cells acquire information for a lifetime. Understanding the molecular mechanisms underlying male germ cell programming and how xenobiotics can disrupt these mechanisms is essential to establish the dependency of reproductive outcomes on fetal programming.
Institut national de la recherche scientifique - $29,… | Canada Spends